# MYeloma Resistance And Clonal Evolution

> **NCT03807128** · — · RECRUITING · sponsor: **Nantes University Hospital** · enrollment: 1400 (estimated)

## Conditions studied

- Multiple Myeloma

## Interventions

- **OTHER:** Prélèvement sanguin (2*4mL) ou médullaire (2mL)
- **OTHER:** Data collection through questionnaires

## Key facts

- **NCT ID:** NCT03807128
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2019-02-11
- **Primary completion:** 2034-02-11
- **Final completion:** 2049-02-11
- **Target enrollment:** 1400 (ESTIMATED)
- **Last updated:** 2025-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03807128

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03807128, "MYeloma Resistance And Clonal Evolution". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03807128. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*